Physiologic Variants of Cardiac Conduction (Aberration, Gap, Supernormal Conduction).
Miles WM, George P.
Cardiol Clin. 2023 Aug;41(3):315-332. doi: 10.1016/j.ccl.2023.03.006.
Does an overlap syndrome really exist between Brugada syndrome and progressive cardiac conduction defect (Lenegre syndrome)?
Shimizu W.
J Cardiovasc Electrophysiol. 2006 Mar;17(3):276-8. doi: 10.1111/j.1540-8167.2006.00406.x.
Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation.
Probst V, Allouis M, Sacher F, Pattier S, Babuty D, Mabo P, Mansourati J, Victor J, Nguyen JM, Schott JJ, Boisseau P, Escande D, Le Marec H.
J Cardiovasc Electrophysiol. 2006 Mar;17(3):270-5. doi: 10.1111/j.1540-8167.2006.00349.x.
Whole exome sequencing identified a pathogenic nonsense mutation in LMNA in a family with a progressive cardiac conduction defect: A case report.
Fan P, Zhang D, Yang KQ, Tian T, Luo F, Liu YX, Wang LP, Zhou XL.
Mol Med Rep. 2020 Jun;21(6):2459-2465. doi: 10.3892/mmr.2020.11048. Epub 2020 Apr 1.
[Congenital Cardiac Conduction Abnormalities].
Mironov NY, Berezina ES, Golitsyn SP.
Kardiologiia. 2015;55(4):83-90. doi: 10.18565/cardio.2015.4.83-90.
Sodium channel haploinsufficiency and structural change in ventricular arrhythmogenesis.
Jeevaratnam K, Guzadhur L, Goh YM, Grace AA, Huang CL.
Acta Physiol (Oxf). 2016 Feb;216(2):186-202. doi: 10.1111/apha.12577. Epub 2015 Sep 24.
Desmin-related myopathy characterized by non-compaction cardiomyopathy, cardiac conduction defect, and coronary artery dissection.
Tamiya R, Saito Y, Fukamachi D, Nagashima K, Aizawa Y, Ohkubo K, Hatta T, Sezai A, Tanaka M, Ishikawa T, Makita N, Sumitomo N, Okumura Y.
ESC Heart Fail. 2020 Jun;7(3):1338-1343. doi: 10.1002/ehf2.12667. Epub 2020 Mar 6.
Identification of a strong genetic background for progressive cardiac conduction defect by epidemiological approach.
Gourraud JB, Kyndt F, Fouchard S, Rendu E, Jaafar P, Gully C, Gacem K, Dupuis JM, Longueville A, Baron E, Karakachoff M, Cebron JP, Chatel S, Schott JJ, Le Marec H, Probst V.
Heart. 2012 Sep;98(17):1305-10. doi: 10.1136/heartjnl-2012-301872. Epub 2012 Jun 19.
Prognostic implications of progressive cardiac conduction disease.
Kawaguchi T, Hayashi H, Miyamoto A, Yoshino T, Taniguchi A, Naiki N, Sugimoto Y, Ito M, Xue JQ, Murakami Y, Horie M.
Circ J. 2013;77(1):60-7. doi: 10.1253/circj.cj-12-0849. Epub 2012 Sep 26.
Cardiac sodium channel diseases.
Napolitano C, Rivolta I, Priori SG.
Clin Chem Lab Med. 2003 Apr;41(4):439-44. doi: 10.1515/CCLM.2003.066.
